227 related articles for article (PubMed ID: 15691277)
1. ATG induction therapy: long-term effects on Th1 but not on Th2 responses.
Weimer R; Staak A; Süsal C; Streller S; Yildiz S; Pelzl S; Renner F; Dietrich H; Daniel V; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
Transpl Int; 2005 Feb; 18(2):226-36. PubMed ID: 15691277
[TBL] [Abstract][Full Text] [Related]
2. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
5. ATG induction in renal transplant recipients: Long-term hazard of severe infection is associated with long-term functional T cell impairment but not the ATG-induced CD4 cell decline.
Weimer R; Ettrich M; Renner F; Dietrich H; Süsal C; Deisz S; Padberg W; Opelz G
Hum Immunol; 2014 Jun; 75(6):561-9. PubMed ID: 24530759
[TBL] [Abstract][Full Text] [Related]
6. Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.
Kyte JA; Trachsel S; Risberg B; thor Straten P; Lislerud K; Gaudernack G
Cancer Immunol Immunother; 2009 Oct; 58(10):1609-26. PubMed ID: 19221745
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus.
Golling M; Sadeghi M; Zipperle S; Fonouni H; Golriz M; Mehrabi A
Clin Transplant; 2009 Dec; 23 Suppl 21():83-91. PubMed ID: 19930321
[TBL] [Abstract][Full Text] [Related]
8. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
9. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.
Glowacki F; Al Morabiti M; Lionet A; Labalette M; Provot F; Noel C; Hazzan M
Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742
[TBL] [Abstract][Full Text] [Related]
10. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
Fowler DH; Odom J; Steinberg SM; Chow CK; Foley J; Kogan Y; Hou J; Gea-Banacloche J; Sportes C; Pavletic S; Leitman S; Read EJ; Carter C; Kolstad A; Fox R; Beatty GL; Vonderheide RH; Levine BL; June CH; Gress RE; Bishop MR
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1150-60. PubMed ID: 17085308
[TBL] [Abstract][Full Text] [Related]
12. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses.
Weimer R; Melk A; Daniel V; Friemann S; Padberg W; Opelz G
Hum Immunol; 2000 Sep; 61(9):884-97. PubMed ID: 11053632
[TBL] [Abstract][Full Text] [Related]
13. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
14. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
Daniel V; Naujokat C; Sadeghi M; Weimer R; Renner F; Yildiz S; Opelz G
Transpl Int; 2008 Jul; 21(7):646-60. PubMed ID: 18298587
[TBL] [Abstract][Full Text] [Related]
15. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
16. Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinib.
Kiani A; Habermann I; Schäke K; Neubauer A; Rogge L; Ehninger G
Haematologica; 2003 Jul; 88(7):754-61. PubMed ID: 12857553
[TBL] [Abstract][Full Text] [Related]
17. Impaired lymphokine secretion in anergic CD4+ T cells leads to defective help for B cell growth and differentiation.
Telander DG; Mueller DL
J Immunol; 1997 May; 158(10):4704-13. PubMed ID: 9144483
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of adaptive immunity to Haemophilus influenzae type b meningitis in transgenic mice: evidence from diverse expression of double T1/T2 transgenes and Th1/Th2-related cytokines.
Chen SJ; Liao CL; Hsieh SL; Chu ML; Fang MC; Sytwu HK; Wang CC
Immunol Lett; 2006 May; 105(1):6-15. PubMed ID: 16384609
[TBL] [Abstract][Full Text] [Related]
19. Effect of moderate exercise training on T-helper cell subpopulations in elderly people.
Shimizu K; Kimura F; Akimoto T; Akama T; Tanabe K; Nishijima T; Kuno S; Kono I
Exerc Immunol Rev; 2008; 14():24-37. PubMed ID: 19203082
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
